Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Collage of Thomas Layton, Lynn Williams and Osaid Alser.

The International Dupuytren Award 2021 for Basic Research was shared between two researchers from the Kennedy Institute of Rheumatology at NDORMS. Lynn Williams was recognised for her paper "Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300" published in PNAS, and Thomas Layton for "Cellular census of human fibrosis defines functionally distinct stromal cell types and states" which appeared in Nature Communications.

The award for Best Clinical Paper award was won by Osaid Alser for the work he completed as MSc by Research student at NDORMS before graduating and moving to Harvard. His paper "Serious complications and risk of re-operation after Dupuytren’s disease surgery: a population-based cohort study of 121,488 patients in England" appeared in Nature Scientific Reports.

Dominic Furniss, who co-supervised Osaid and Thomas, said: “My congratulations go to our researchers who have been recognised for their work by the International Dupuytren Society. The research explores the underlying causes of Dupuyren’s disease and helps us move towards improving treatment for this disabling condition.”

The International Dupuytren Award recognises exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease. 

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.